Stay updated with breaking news from Vitro Diagnostics Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEOUL, South Korea (PRWEB) October 28, 2021 -- Deep Bio, a pioneer in medical AI specialized for cancer diagnostics, announced a strategic relationship with a
SEOUL, South Korea (PRWEB) October 18, 2021 -- Deep Bio, a pioneer in medical AI specialized for cancer diagnostics, announced that new study results on
GENEVA, Switzerland (PRWEB) October 18, 2021 -- Healthcare Konnect, a Swiss medical device distribution company, and Deep Bio Inc., a South Korean leader in
SEOUL, South Korea (PRWEB) August 13, 2021 -- Deep Bio, a leading AI biotech dedicated to pathologic cancer diagnosis and prognosis, announced an on-going
SEOUL, South Korea, July 23, 2021 /PRNewswire-PRWeb/ — Deep Bio, a leading company in digital pathology and cancer diagnostics, today announced a renewal of their Research Collaboration Agreement with Dana-Farber Cancer Institute aimed at evaluating prostate cancer tumors. This collaboration with Dana-Farber is a part of the Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium, a global collaboration formed to evaluate the high burden of prostate cancer in the Sub-Saharan African (SSA) population. Dana-Farber is a principal teaching affiliate of Harvard Medical School a...